The long term goals of this program are to elucidate mechanisms of control of thyrotropin-releasing hormone (TRH)-producing neurons in the hypothalamic paraventricular nucleus (PVN) that comprise a critical component of the hypothalamic-pituitary-thyroid (HPT) axis, and to determine how these neurons alter their response to feedback signals by thyroid hormone during adaptive and pathological conditons that give rise to the nonthyroidal illness syndrome observed in man. The possibility that the monocarboxylate transporter 8 (MCT8) and steroid receptor co-activator (SRC-1) contribute to feedback regulation of hypophysiotropic TRH will be explored in transgenic mice in which MCT8 or SRC-1 is selectively removed from TRH-producing cells. Mechanisms whereby leptin, AGRP, and a-MSH regulate TRH neurons in the PVN during fasting and refed states will be studied in the neuronal selective POMC KO mouse and by using transgenic mice that express Cre recombinase selectively in TRH-producing cells. We will further study the role of AMP-activated protein kinase to mediate inhibitory effects of AGRP on hypophysiotropic TRH and the importance of glutamate/ cannabinoid interactions as a mechanism involved in fasting-induced suppression the HPT axis. The importance of the hypothalamic dorsomedial nucleus (DMN) as a metabolic sensor for TRH neurons in the PVN will be explored, and the hypothesis tested that the DMN integrates signals from the arcuate nucleus and subparaventricular zone that are responsible for the circadian periodicity of the HPT axis. Mechanisms by which endotoxin suppress the HPT axis will be studied, focusing on effects mediated by the cAMP-response element modulator (CREM), inducible cAMP early represser (ICER) and/or corticotropin-releasing hormone (CRH). We will also determine whether LPS-induced activation of type 2 iodothyronine deiodinase (D2), an enzyme critical for conversion of thyroxine (T4) into its active form triiodothyronine (T3) and highly expressed in tanycytes, downregulates the HPT axis by increasing local tissue levels of T3. Finally, we will explore the possibility that in addition to the central effects on hypophysiotropic TRH neuronal cell bodies, endotoxin has a dual inhibitory effect on TRH neurons as a result of inducing morphologic rearrangement of tanycyte endfeet processes in association with TRH-containing axon terminals in the external zone of the median eminence.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
High Priority, Short Term Project Award (R56)
Project #
2R56DK037021-22
Application #
7432791
Study Section
Molecular and Cellular Endocrinology Study Section (MCE)
Program Officer
Sato, Sheryl M
Project Start
1986-02-01
Project End
2007-09-24
Budget Start
2007-06-01
Budget End
2007-09-24
Support Year
22
Fiscal Year
2007
Total Cost
$200,714
Indirect Cost
Name
Tufts University
Department
Type
DUNS #
079532263
City
Boston
State
MA
Country
United States
Zip Code
02111
Wittmann, Gábor; Szabon, Judit; Mohácsik, Petra et al. (2015) Parallel regulation of thyroid hormone transporters OATP1c1 and MCT8 during and after endotoxemia at the blood-brain barrier of male rodents. Endocrinology 156:1552-64
Wittmann, Gábor; Harney, John W; Singru, Praful S et al. (2014) Inflammation-inducible type 2 deiodinase expression in the leptomeninges, choroid plexus, and at brain blood vessels in male rodents. Endocrinology 155:2009-19
Fekete, Csaba; Lechan, Ronald M (2014) Central regulation of hypothalamic-pituitary-thyroid axis under physiological and pathophysiological conditions. Endocr Rev 35:159-94
Singru, Praful S; Wittmann, Gabor; Farkas, Erzsebet et al. (2012) Refeeding-activated glutamatergic neurons in the hypothalamic paraventricular nucleus (PVN) mediate effects of melanocortin signaling in the nucleus tractus solitarius (NTS). Endocrinology 153:3804-14
Fekete, C; Zseli, G; Singru, P S et al. (2012) Activation of anorexigenic pro-opiomelanocortin neurones during refeeding is independent of vagal and brainstem inputs. J Neuroendocrinol 24:1423-31
Sarvari, Anna; Farkas, Erzsebet; Kadar, Andrea et al. (2012) Thyrotropin-releasing hormone-containing axons innervate histaminergic neurons in the tuberomammillary nucleus. Brain Res 1488:72-80
Marsili, Alessandro; Sanchez, Edith; Singru, Praful et al. (2011) Thyroxine-induced expression of pyroglutamyl peptidase II and inhibition of TSH release precedes suppression of TRH mRNA and requires type 2 deiodinase. J Endocrinol 211:73-8
Rosene, Matthew L; Wittmann, Gabor; Arrojo e Drigo, Rafael et al. (2010) Inhibition of the type 2 iodothyronine deiodinase underlies the elevated plasma TSH associated with amiodarone treatment. Endocrinology 151:5961-70
Sanchez, Edith; Singru, Praful S; Wittmann, Gabor et al. (2010) Contribution of TNF-alpha and nuclear factor-kappaB signaling to type 2 iodothyronine deiodinase activation in the mediobasal hypothalamus after lipopolysaccharide administration. Endocrinology 151:3827-35
Freitas, Beatriz C G; Gereben, Balazs; Castillo, Melany et al. (2010) Paracrine signaling by glial cell-derived triiodothyronine activates neuronal gene expression in the rodent brain and human cells. J Clin Invest 120:2206-17

Showing the most recent 10 out of 17 publications